22 Results for "

Pro3

" in MedChemExpress (MCE) Product Catalog:
Products (22)

22 Results for "Pro3" in MCE Product Catalog:

Cat. No.: HY-P1434
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

[Pro3]-GIP (mouse) is a GIP receptor antagonist (IC50: 2.6 μM). [Pro3]-GIP (mouse) improves glucose tolerance and insulin sensitivity in ob/ob mice. [Pro3]-GIP (mouse) can be used for research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-P3584A
Synonyms: (Pro3) Gastric Inhibitory Peptide, human TFA
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

(Pro3) GIP, human TFA is an efficacious, stable and specific human GIP receptor (hGIPR) full agonist. (Pro3) GIP, human TFA has high binding affinity for human GIPR with Ki/ Kd value of 0.90 nM. (Pro3) GIP, human TFA human can be used for the research of obesity-related diabetes .
loading...
    loading...
Cat. No.: HY-117070
CAS No.: 157199-63-8
Purity:  99.00%
TO-PRO-3 iodide is a cell-impermeant nucleic acid stain. TO-PRO-3 iodide is useful as a nuclear counterstain and dead cell indicator (Ex/Em = 642/661 nm).
loading...
    loading...
Cat. No.: HY-P3584
CAS No.: 299898-52-5
Synonyms: (Pro3) Gastric Inhibitory Peptide, human
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

(Pro3) GIP, human ((Pro3) Gastric Inhibitory Peptide, human) is an efficacious, stable and specific human GIP receptor (hGIPR) full agonist. (Pro3) GIP, human has high binding affinity for human GIPR with Ki/ Kd values of 0.90 nM. (Pro3) GIP, human can be used for the research of obesity-related diabetes .
loading...
    loading...
Cat. No.: HY-P1130
CAS No.: 908844-75-7
Synonyms: Galanin-(2-13)-Glu-His-(Pro)3-(Ala-Leu)2-Ala-amide
M871 (Galanin-(2-13)-Glu-His-(Pro)3-(Ala-Leu)2-Ala-amide) is an orally active and selective galanin receptor type 2 (GalR2) antagonist. M871 exhibits Ki values of 13.1 nM, 420 nM and >10 μM for GalR2, GalR1 and GalR3 respectively. M871 relieves the mice allergic rhinitis by reducing IgE production, as well as the number of B cells in tissues. M871 can inhibit the nerve invasion of salivary adenoid cystic carcinoma (SACC) and alleviate myocardial ischemia-reperfusion injury. M871 can be used for research on GalR2-related diseases (such as epilepsy, pain) [3] .
loading...
    loading...
Cat. No.: HY-P3666
CAS No.: 64789-67-9
Target:  

GnRH Receptor

Research Areas:  

Endocrinology

[D-Phe2,6, Pro3]-LH-RH is a potent luteinizing hormone releasing hormone (LHRH) antagonist .
loading...
    loading...
Cat. No.: HY-P11455A
Target:  

Liposome

Research Areas:  

Others

Lipopeptide CPE4 TFA is a PEG-modified peptide E4 [(EIAALEK) 4]. Lipopeptide CPE4 TFA is capable of coiled-coil formation when attached to liposomes. Lipopeptide CPE4 TFA triggers membrane fusion between liposomes and living cells with concomitant efficient cytosolic delivery of a variety of compounds such as fluorescent dyes Propidium Iodide (PI) (HY-D0815) and TO-PRO-3 iodide (HY-117070), and Doxorubicin (DOX) (HY-15142A). Lipopeptide CPE4 TFA can be used for drug delivery research .
loading...
    loading...
Cat. No.: HY-P1433
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

[Pro3]-GIP (Rat) is a selective GIP receptor partial agonist with a Ki of 13 nM. [Pro3]-GIP (Rat) can be used in diabetes research .
loading...
    loading...
Cat. No.: HY-122259
CAS No.: 41600-13-9
Target:  

Antifolate

Research Areas:  

Cancer

AMPte-Glu-γ-Glu is a substrate for folylpoly-γ-glutamate synthetase (FPGS). AMPte-Glu-γ-Glu exhibits cytotoxicity against chinese hamster ovaries cells, with IC50s of 20, 350 and 3 nM, for Pro3, R2, and 43-10, respectively .
loading...
    loading...
Cat. No.: HY-144062
CAS No.: 2735704-33-1
Target:  

SARS-CoV

Research Areas:  

Infection

INSCoV-614(1B) is a potent inhibitor of M pro (3CL pro). Proteases (PL pro and 3CL pro) are involved with transcription and replication of the virus. INSCoV-614(1B) has the potential for the research of SARS-CoV-2 infection (extracted from patent WO2021219089A1) .
loading...
    loading...
Cat. No.: HY-P11456A
Target:  

Liposome

Research Areas:  

Others

Lipopeptide CPK4 TFA is a Cholesterol (HY-N0322)-modified peptide K4 [(KIAALKE) 3]. Lipopeptide CPK4 TFA is capable of coiled-coil formation when attached to liposomes. Lipopeptide CPK4 TFA triggers membrane fusion between liposomes and living cells with concomitant efficient cytosolic delivery of a variety of compounds such as fluorescent dyes Propidium Iodide (PI) (HY-D0815) and TO-PRO-3 iodide (HY-117070), and Doxorubicin (DOX) (HY-15142A). Lipopeptide CPK4 TFA can be used for drug delivery research .
loading...
    loading...
Cat. No.: HY-P4546
CAS No.: 553644-01-2
Research Areas:  

Others

Abz-Ser-Pro-3-nitro-Tyr is the substrate of ACE2 (angiotensin-converting enzyme-2) .
loading...
    loading...
Cat. No.: HY-RS11486
Research Areas:  

Others

PYCR1 Human Pre-designed siRNA Set A contains three designed siRNAs for PYCR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P89148
Synonyms: ARCL2B; ARCL3B; P5C; P5CR; PIG45; PP222; Pro3; PYCR

Host:  

Mouse

Application:  

IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P89148A
Synonyms: ARCL2B; ARCL3B; P5C; P5CR; PIG45; PP222; Pro3; PYCR

Host:  

Mouse

Application:  

IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-170819
Target:  

SARS-CoV Cathepsin

Research Areas:  

Infection

VK13 (Compound 6) is a potent inhibitor of human cathepsin L (hCatL) with a Ki value of 0.55 nM and SARS-CoV-2 3CL pro (3CL-PR) with a Ki value of 2.6 nM. VK13 exhibits anti-CoV-2 activity with an EC50 of 1.25 μM .
loading...
    loading...
Cat. No.: HY-144061
CAS No.: 2735704-19-3
Target:  

SARS-CoV

Research Areas:  

Infection

INSCoV-601I(1) is a potent inhibitor of M pro (3CL pro). Proteases (PL pro and 3CL pro) are involved with transcription and replication of the virus. INSCoV-601I(1) has the potential for the research of SARS-CoV-2 infection (extracted from patent WO2021219089A1) .
loading...
    loading...
Cat. No.: HY-144063
CAS No.: 2735704-15-9
Target:  

SARS-CoV

Research Areas:  

Infection

INSCoV-600K(1) is a potent inhibitor of M pro (3CL pro). Proteases (PL pro and 3CL pro) are involved with transcription and replication of the virus. INSCoV-600K(1) has the potential for the research of SARS-CoV-2 infection (extracted from patent WO2021219089A1) .
loading...
    loading...
Cat. No.: HY-144833
CAS No.: 2757970-20-8
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 3CLpro-IN-1 (Compound 14c) is a potent inhibitor of SARS-CoV-2 3CL pro. 3CL pro (main coronaviruses cysteine-protease) has been identified as a promising target for the development of antiviral agents. SARS-CoV-2 3CLpro-IN-1 has the potential for the research of infection diseases .
loading...
    loading...
Cat. No.: HY-P11455
Target:  

Liposome

Research Areas:  

Others

Lipopeptide CPE4 is a PEG-modified peptide E4 [(EIAALEK) 4]. Lipopeptide CPE4 is capable of coiled-coil formation when attached to liposomes. Lipopeptide CPE4 triggers membrane fusion between liposomes and living cells with concomitant efficient cytosolic delivery of a variety of compounds such as fluorescent dyes Propidium Iodide (PI) (HY-D0815) and TO-PRO-3 iodide (HY-117070), and Doxorubicin (DOX) (HY-15142A). Lipopeptide CPE4 can be used for drug delivery research .
loading...
    loading...